"10.1371_journal.pone.0052383","plos one","2012-12-26T00:00:00Z","Tatsuhiko Ozawa; Xiuhong Piao; Eiji Kobayashi; Yue Zhou; Hiroaki Sakurai; Tsugunobu Andoh; Aishun Jin; Hiroyuki Kishi; Atsushi Muraguchi","Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Department of Immunology, College of Basic Medical Sciences, Harbin Medical University, Nangang District, Harbin, China","Conceived and designed the experiments: TO EK HS AJ HK AM. Performed the experiments: TO XP YZ TA. Analyzed the data: TO XP HS HK AM. Wrote the paper: TO HK AM.","AM was supported by a research fund from Vivalis (Nantes, France.) The ISAAC method is covered by patents that have been exclusively licensed to Vivalis (Nantes, France.) Patent details: Pub.No.: WO/2009/017226, International Application No.: PCT/JP2008/063874, Title: CELL SCREENING METHOD; HK is one of Scientific Advisory Board Members of Vivalis. Microwell array chips are now provided to us by Vivalis. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€² adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","12","Tatsuhiko Ozawa","TO",9,TRUE,6,4,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
